No significant differences in age, sex, tumor size, clinical T status, clinical N status, vascular invasion, perineural invasion, clinical TNM stage, pretreatment serum CEA level, and posttreatment serum CEA level were observed (all P > 0.05). This evidence concerns the gene CEACAM5 and neoplasm.